The global large joint reconstruction market will likely grow at a 6.1 percent compound annual growth rate through 2023, based on an Orian Research analysis, according to medGadget.
Here are three points:
1. Key market drivers include a growing number of orthopedic conditions and an increasing number of unhealthy diets and lifestyles.
2. The growing popularity of minimally invasive surgeries and rising research and development activities will also enhance the market.
3. Dominant market players include Stryker, DePuy Synthes, Zimmer Biomet, Integra LifeSciences, Arthrex, Smith & Nephew, Consensus Orthopedics, Exactech and Microport.